PDGF β-Receptor Kinase Activity and ERK1/2 Mediate Glycosaminoglycan Elongation on Biglycan and Increases Binding to LDL

Robel Getachew(Baker Heart and Diabetes Institute), Narin Osman(Baker Heart and Diabetes Institute)
Endocrinology
July 7, 2010
Cited by 56


Related Papers